These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1284753)

  • 1. [New possibilities in diagnosing hemolytic disease of newborn infants].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Beitr Infusionsther; 1992; 30():431-5. PubMed ID: 1284753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New possibilities in diagnosis of hemolytic diseases in newborns].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):208-13. PubMed ID: 1422082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern diagnosis and therapy of fetomaternal blood group incompatibility].
    Vetter K; Favre Y
    Arch Gynecol Obstet; 1990; 247 Suppl():S25-35. PubMed ID: 2128174
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy in fetuses at risk in Rh isoimmunization].
    Calda P; Zizka Z; Rezábek K; Masata J; Bendl J
    Cesk Gynekol; 1993 Dec; 58(6):278-82. PubMed ID: 8293503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the affinity of anti-D in the serum of immunized mothers and in immunoglobulin preparations with unlabeled antibodies.
    Debbia M; Brossard Y; Lambin P
    Transfusion; 2005 Jun; 45(6):975-83. PubMed ID: 15934997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perinatal hemolytic disease caused by anti-c. A clinical case].
    Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
    Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic possibilities in incompatibility processes].
    Kozlowski P
    Gynakologe; 1990 Jun; 23(3):172-7. PubMed ID: 2117563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Systematic detection of anti-erythrocyte alloimmunization during pregnancy. Experience at the Lyon Regional Blood Transfusion Center].
    Moncharmont P; Juron-Dupraz F; Vignal M; Rigal D
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):321-4. PubMed ID: 2500475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhesus erythroblastosis, monitoring and treatment].
    Siebers JW; Rasenack R; Hillemanns HG
    Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.